HeXun Biosciences Co., Ltd. (TPEX:6986)
Taiwan · Delayed Price · Currency is TWD 42.90
-0.05 (-0.12%)
Aug 19, 2026, 1:30 PM CST
HeXun Biosciences Market Cap
HeXun Biosciences has a market cap or net worth of 2.24 billion as of August 19, 2026. Its market cap has decreased by -23.70% in one year.
Market Cap
2.24B
Enterprise Value
1.44B
Revenue
308.21M
Ranking
n/a
PE Ratio
17.04
Stock Price
42.90
ChartMarket Cap Chart
Since September 7, 2023, HeXun Biosciences's market cap has decreased from 4.16B to 2.24B, a decrease of -46.15%. That is a compound annual growth rate of -18.92%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 19, 2026 | 2.24B | -22.73% |
| Dec 31, 2025 | 2.90B | -6.67% |
| Dec 31, 2024 | 3.11B | 4.17% |
| Dec 29, 2023 | 2.98B | -28.32% |
| Sep 7, 2023 | 4.16B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Intech Biopharm | 2.87B |
| BRIM Biotechnology | 2.71B |
| Chunghwa Chemical Synthesis & Biotech | 2.69B |
| Energenesis Biomedical CO.,LTD. | 2.67B |
| GlycoNex Incorporation | 2.53B |
| Syngen Biotech | 2.36B |
| Taiwan Bio Therapeutics | 2.19B |
| Sunhawk Vision Biotech | 2.00B |